Wall Street brokerages expect Liquidia Co. (NASDAQ:LQDA) to report ($0.12) earnings per share for the current quarter, Zacks reports. Three analysts have issued estimates for Liquidia’s earnings, with estimates ranging from ($0.15) to ($0.06). Liquidia reported earnings per share of ($0.40) during the same quarter last year, which would indicate a positive year over year growth rate of 70%. The company is scheduled to report its next quarterly earnings report on Monday, November 8th.
According to Zacks, analysts expect that Liquidia will report full year earnings of ($0.58) per share for the current financial year, with EPS estimates ranging from ($0.70) to ($0.41). For the next year, analysts anticipate that the business will report earnings of ($0.62) per share, with EPS estimates ranging from ($0.89) to ($0.32). Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of analysts that follow Liquidia.
Liquidia (NASDAQ:LQDA) last released its quarterly earnings data on Monday, August 9th. The company reported ($0.13) EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.16) by $0.03.
Liquidia stock traded up $0.08 during trading hours on Wednesday, hitting $2.69. 3,282 shares of the stock traded hands, compared to its average volume of 742,724. The firm’s 50-day moving average price is $2.56 and its two-hundred day moving average price is $2.69. The company has a market cap of $139.81 million, a PE ratio of -2.40 and a beta of 0.08. Liquidia has a one year low of $2.25 and a one year high of $6.34.
A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. BlackRock Inc. raised its holdings in Liquidia by 6.1% in the 1st quarter. BlackRock Inc. now owns 2,267,418 shares of the company’s stock worth $6,099,000 after acquiring an additional 129,557 shares during the last quarter. Vanguard Group Inc. raised its stake in Liquidia by 21.8% during the 2nd quarter. Vanguard Group Inc. now owns 1,507,235 shares of the company’s stock valued at $4,311,000 after buying an additional 270,238 shares during the last quarter. Millennium Management LLC raised its stake in Liquidia by 31.1% during the 2nd quarter. Millennium Management LLC now owns 1,109,724 shares of the company’s stock valued at $3,174,000 after buying an additional 263,466 shares during the last quarter. Geode Capital Management LLC raised its stake in Liquidia by 41.4% during the 1st quarter. Geode Capital Management LLC now owns 529,855 shares of the company’s stock valued at $1,425,000 after buying an additional 155,203 shares during the last quarter. Finally, Eversept Partners LP purchased a new stake in Liquidia during the 1st quarter valued at $1,345,000. Institutional investors own 20.48% of the company’s stock.
Liquidia Corp. operates as a holding company which through its subsidiary engages in developing and commercializing biopharmaceutical products. It engages in novel products development used in PRINT technology to transform the lives of patients. PRINT is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy and performance of a wide range of therapies.
Featured Article: What are momentum indicators and what do they show?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Liquidia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia and related companies with MarketBeat.com's FREE daily email newsletter.